|
In April 2002, The
Journal of Alternative and Complementary Medicine, a highly
esteemed medical journal,
accepted for publication the entire research manuscript
outlining the remarkable successful clinical trial results of
HairGenesis™ products from an independently
verified, clinically proven,
published FDA-regulated,
IRB-monitored (Institutional Review Board) Peer-Reviewed,
Placebo-Controlled, Double-Blind Clinical Study
"A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of a Novel Formulation Comprised of Botanically Derived Inhibitors of 5AR in the Treatment of
AndroGenetic Alopecia".
(5AR Inhibitors refers to DHT Blockers)
This independently conducted
HairGenesis research study represents
the first report of the successful use of a
naturally derived
hair loss treatment formulation against
AndroGenetic Alopecia
(pattern hair loss). This clinical trial heralds a major paradigm shift in the standard clinical approaches in treating pattern hair loss, since it introduces
HairGenesis as a safe and efficacious alternative to the pharmaceutically derived drugs
Rogaine and
Propecia. The research manuscript outlining this remarkable clinical trial was published within the April 2002 edition of the
Journal of Alternative and Complementary
Medicine. The published study manuscript is currently available in its entirety on this web site as a PDF download.
HairGenesis has been designed with the understanding that individual botanical substances have previously demonstrated remarkable benefit against androgen-mediated hormonal processes that also lead to hair loss. In developing these oral and topical formulations, a regimen has been developed which is unique in design as well as efficacy.
For those wishing to develop a deeper understanding of the details involved in this subject, we have provided a selection of relevant clinical research leading to the invention of HairGenesis.
|